ArticleBMJ open2021

CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.

Tonny Veenith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.